Scott Kaufmann, MD
Enriched profileProfessor of Pharmacology and Medicine, Consultant in Oncology and Hematology · Mayo Clinic College of Medicine
Scott Kaufmann is Professor of Pharmacology and Medicine, Consultant in Oncology and Hematology at Mayo Clinic College of Medicine. OpenAlex indexes 972 publications with 50,602 citations (h-index 111); ClinicalTrials.gov lists 4 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Hematology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Scott H. Kaufmann, MD, is Professor of Pharmacology and Medicine, Consultant in Oncology and Hematology at Mayo Clinic College of Medicine. The public record shows 972 publications with 50,602 citations (h-index 111), centered on Hematology. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 2 companies, 17 NIH-funded awards (1994–2026).
- Most recent indexed publication: 2026 · Blood
- Top research focus: Hematology
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 50 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Industry payments
Updated 27 Aug 2026
2 companies reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Clovis Oncology, Inc.Program year20214 payments
- Abbott LaboratoriesProgram year20212 payments
NIH funding
Updated 27 Aug 2026
17 NIH research awards on record, funded 1994–2026 per NIH RePORTER. The latest:
- Therapy of PARP inhibitor-associated myeloid neoplasms in ovarian cancer patients
Mayo Clinic Rochester
FY2026$462,795R01CA289285
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Dual FAK and EPHA2 targeting by brigatinib tackles PARP inhibitor adaptive survival response in high-grade serous ovarian cancer.
Science translational medicine
Article2026 - CHFR expression and sensitivity of breast cancer cells to antimitotic agents in vitro and in the I-SPY trial.
NPJ breast cancer
Article2025 - Codon specific readthrough as a mechanism of BRCA2 restoration in acquired PARP inhibitor and chemotherapy resistance.
Nucleic acids research
Article2025
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/scott-kaufmann-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/scott-kaufmann-4a367035
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
mayo.edu/research/faculty/kaufmann-scott-h-m-d-ph-d/bio-00027216
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗
Mentions by others
where others cite or feature them- X / Twitter
twitter.com/MayoHemeOnc
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →twitter.com ↗ - LinkedIn
LinkedIn profile: Scott Kaufmann - Mayo Clinic
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Doximity
Doximity profile: Dr. Scott Kaufmann, MD - Rochester, MN, Hematology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗
Editorial & leadership roles
journal and society appointments- Consultant
Division of Hematology, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Principal Investigator
Anticancer Drug Action laboratory, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- Mayo Clinic Hospital
Saint Marys Campus (clinical affiliation)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Tait Shanafelt, MD
Palo Alto University
Robert Bast, MD
The University of Texas MD Anderson Cancer Center
Thomas Witzig, MD
Mayo Clinic